The rectal administration of lignocaine gel and periprostatic lignocaine infiltration during transrectal ultrasound-guided prostate biopsy provides effective analgesia
- PMID: 16551424
- PMCID: PMC1964051
- DOI: 10.1308/003588406X95048
The rectal administration of lignocaine gel and periprostatic lignocaine infiltration during transrectal ultrasound-guided prostate biopsy provides effective analgesia
Abstract
Introduction: Transrectal ultrasound guided prostate needle biopsy (TRUS) is the standard procedure to diagnose or exclude prostate cancer. This procedure can be associated with significant discomfort, both on insertion of the ultrasound probe as well as on taking the biopsy. We evaluated a new technique for pain relief during TRUS biopsy.
Patients and methods: In Group 1 (n = 60), the biopsies were taken without any analgesia. In Group 2 (n = 60), 11 ml of Instillagel (2% lignocaine) was administered rectally prior to probe insertion and 5 ml of 1% lignocaine periprostatic injection was administered before taking the biopsy. The discomfort encountered during the procedure was graded by the patient on a scale ranging from no discomfort to mild, moderate and severe pain.
Results: In Group 2, there was a marked reduction in the pain experienced during the procedure. The Chi-squared test for trend showed a significant association between the rectal administration of local anaesthetic gel and reduction in pain on probe insertion (P = 0.0001). There was also a significant association between the use of periprostatic lignocaine injection and reduction in pain on taking the biopsy (P < 0.0001).
Conclusions: The use of lignocaine gel prior to probe insertion and periprostatic infiltration of lignocaine before taking the needle biopsy significantly reduces the pain experienced by the patient during TRUS-guided prostate biopsy.
Figures
References
-
- Wingo PA, Tong T, Bolden S. Cancer statistics 1995. CA Cancer J Clin. 1995;45:8–30. - PubMed
-
- Landis SH, Murray T, Bolden S, Wingo P. Cancer statistics 1998. CA Cancer J Clin. 1998;48:6–29. - PubMed
-
- Stamey TA. Making the best out of six systemic sextant biopsies. Urology. 1995;45:2–12. - PubMed
-
- Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997;157:199–202. - PubMed
-
- Ravery V, Goldblatt L, Royer B, Blanc E, Toublanc M, Bocco-Gibod L. Extensive biopsy protocol improves the detection rate of prostate cancer. J Urol. 2000;164:393–6. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical